← SynDRA

RITLECITINIB

SynDRA canonical compound SYN0039265 — structure-anchored drug synonym record

All known targets

• JAK3
• BMX
• BTK
• ITK
• TEC
• TXK
• BLK
• ERBB4
• JAK1

Mechanisms of action (all sources)

• JAK3 INHIBITOR
• Tyrosine-protein kinase JAK3 inhibitor
• ITK INHIBITOR
• TEC family kinase inhibitor
• BMX INHIBITOR
• TEC INHIBITOR
• TXK INHIBITOR
• BTK INHIBITOR
• JAK inhibitor

Drug classes

• Janus Kinase Inhibitors
• Tyrosine Kinase Inhibitors

ATC classes

• L04A · IMMUNOSUPPRESSANTS

Cross-references

• PubChem CID: 118115473
• ChEMBL: CHEMBL4085457
• DrugBank: DB14924
• ChEBI: 229233
• KEGG: D11970
• RxNorm: 2641595
• Wikipedia: Ritlecitinib
• TTD: D02TUL

Synonyms

• ritlecitinib tosylate
• PF-06651600
• litfulo
• CBRJPFGIXUFMTM-WDEREUQCSA-N
• UNII-2OYE00PC25
• 2OYE00PC25
• PF06651600
• 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
• GTPL9559
• SCHEMBL16764638
• BCP24778
• EX-A2613
• ZINC526061581
• example 5 [WO2015083028]
• ACN-040697
• compound 11 [PMID: 28139931]
• HY-100754
• CS-0020243
• 1-[(2S,5R)-2-Methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-2-propen-1-one malonate
• 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one
• PF 06651600
• RefChem:179511
• JAK3 Inhibitor PF-06651600
• MFCD30343868
• ritlecitinibum
• PF-06651600 free base
• MFCD31697544
• RITLECITINIB [INN]
• RITLECITINIB [WHO-DD]
• orb1301838
• SCHEMBL24377696
• SCHEMBL29369472
• CHEBI:229233
• RITLECITINIB (PF-06651600)
• AKOS040758742
• CCG-267324
• EBC-221083
• NCGC00501213-04